Cargando…
Vasculoprotective effects of rosiglitazone through modulating renin-angiotensin system in vivo and vitro
BACKGROUND: The peroxisome proliferator-activated receptor-γ (PPARγ) agonist rosiglitazone has been suggested to exert cardiovascular protection through the improvement of lipid metabolism, anti-inflammation, anti-proliferation etc. However, whether renin-angiotensin system (RAS) is involved in the...
Autores principales: | Ren, Liqun, Liu, Naifeng, Zhi, Hong, Li, Yingjuan, Li, Yanzhi, Tang, Rining, Sheng, Zulong |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3039565/ https://www.ncbi.nlm.nih.gov/pubmed/21269478 http://dx.doi.org/10.1186/1475-2840-10-10 |
Ejemplares similares
-
Hydrogen sulfide as a vasculoprotective factor
por: Streeter, Eloise, et al.
Publicado: (2013) -
Vasculoprotective Effects of Vildagliptin. Focus on Atherogenesis
por: Wiciński, Michał, et al.
Publicado: (2020) -
Rosiglitazone, a Ligand to PPARγ, Improves Blood Pressure and Vascular Function through Renin-Angiotensin System Regulation
por: Sánchez-Aguilar, María, et al.
Publicado: (2019) -
Vasculoprotective Potential of Baicalein in Angiotensin II-Infused Abdominal Aortic Aneurysms through Inhibiting Inflammation and Oxidative Stress
por: Sulistyowati, Erna, et al.
Publicado: (2023) -
Angiotensin II mediates the high-glucose-induced endothelial-to-mesenchymal transition in human aortic endothelial cells
por: Tang, Rining, et al.
Publicado: (2010)